InTRoduCTIon
Infections by carbapenem-resistant Enterobacteriaceae (CRE), especially carbapenem-resistant K. pneumoniae (CRKP), are a significant public health challenge worldwide [1] . K. pneumoniae carbapenemase (KPC)-type enzymes in CRKP strains were first reported in 2001 in North Carolina [2] , and they have subsequently spread worldwide. Because KPC carbapenemases are plasmid encoded [3] , they are able to spread antibiotic resistance to various micro-organisms, including the most common human pathogens. Commonly described as 'nightmare bacteria' [4] , these microbes potentially pose a 'catastrophic threat' [5] . The European Society of Clinical Microbiology and Infectious Disease (ESCMID) issued a warning for an impending 'antibiotic Armageddon' [6] as a result of the spread of multidrug-resistant strains.
In the last decade, CRKP has become endemic in several countries, including Greece, while outbreaks of bloodstream infections (BSIs) caused by this pathogen continue to be increasingly reported worldwide [7] . The first Greek CRKP outbreak was recorded in 2009 in the intensive care unit (ICU) of a university hospital on the island of Crete [8] . Since then, CRKP has spread rapidly across the country. According to European Antimicrobial Resistance Surveillance Network (EARS-Net) data, Greece had the highest percentage of carbapenem-resistant isolates among invasive K. pneumoniae in Europe in 2016, as more than 65% of the K. pneumoniae isolates were carbapenem resistant [9] .
K. pneumoniae can survive for several hours on the hands of hospital personnel, which likely facilitates nosocomial spread [10] , and it can reside in the gastrointestinal tract of hospitalized patients without causing any signs of infection [11] . These asymptomatically colonized patients also serve as a significant reservoir for subsequent transmission, leading to further pathogen spread and outbreaks [12] . Therefore, the early identification of risk factors for rectal colonization and subsequent BSI may reduce the morbidity and mortality of ICU patients. Furthermore, critically ill patients are at high risk of colonization and infection by multidrug-resistant organisms due to their prolonged hospital stays, repeated broad-spectrum antibiotic exposure and elevated rates of medical device use [13] .
Thus, the aim of this study was to determine the risk factors for CRKP rectal colonization as well as the incidence of and risk factors for subsequent BSI using molecular methods to explore the clonal relatedness of CRKP strains.
METHodS

Study design, patient population and hospital setting
This study was a prospective study implemented for 39 months at the 'G.GENNIMATAS' General Hospital, a tertiary university hospital in Thessaloniki, Greece. All adults admitted to the eight-bed medical and surgical ICU from June 2011 to August 2014 were enrolled in our study. Patients with an ICU stay of ≤48 h who were known to be colonized by CRKP prior to ICU admission or who were identified as being colonized during the first 24 h were excluded from this study.
This study was divided into three steps. Initially, a time-toevent analysis was conducted in which the time from admission to colonization and/or BSI was evaluated. The second step was to compare the characteristics of CRKP-colonized patients with non-colonized patients (case-control study). Finally, we attempted to identify risk factors for CRKP infection among the colonized patients. The characteristics of the CRKP-colonized patients who developed subsequent CRKP BSIs (cases) were then compared with those who did not develop BSIs (controls from the case-cohort study). Written informed consent was obtained by legal representatives, and the study protocol was approved by the Ethics Committee of the Scientific Council at 'G. GENNIMATAS' General Hospital (Greece) and was in accordance with the Helsinki Declaration of Human Rights.
data collection
Medical data were obtained from the patients' medical records and Hospital Infection Control Committee reports. Demographic characteristics (age and gender), patient origin at the time of admission, illness severity, underlying diseases (malignancy; diabetes mellitus; renal insufficiency; immunodeficiency, including chronic granulomatous disease, common variable immune deficiency, and secondary immune deficiency states (such as the use of steroids, monoclonal antibodies, and other immunosuppressive agents); and cardiopulmonary disease), APACHEII score (Acute Physiology and Chronic Health Evaluation; www. sfar. org/ scores2/ apache22. php) [14] , predicted death rate (PDR), adjusted PDR, surgical history, use of antimicrobials (categorized by class), duration of ICU stay, patient/nurse ratio and clinical outcome were recorded and analysed.
To estimate the severity of illness at admission, patients were evaluated using a modified McCabe scale (1. expected to live more than 2 years, 2. expected to die within 2 years and 3. expected to die within 2 months), as previously described [15] . Antimicrobial exposure was considered only when it occurred within the 6 months prior to ICU admission or within the ICU.
The antibiotics used were classified as follows: combination beta-lactams with beta-lactamase inhibitors, third-and fourth-generation cephalosporins, carbapenems, fluoroquinolones, aminoglycosides, metronidazole, clindamycin, colistin, tigecycline, glycopeptides, linezolid and daptomycin. Antimicrobials that disturb the enteral flora were considered and included the following: penicillins, cephalosporins, carbapenems, beta-lactamase inhibitors, clindamycin, glycopeptides, linezolid, tigecycline and metronidazole [16] .
Microbiological procedures
Screening samples
CRKP colonization was assessed through rectal swabs obtained from all patients within 48 h of admission and again twice a week afterwards until discharge or death. The samples were collected using a nylon flocked swab system with 5 ml of Amies gel transport medium. Samples were immediately transferred to the laboratory for processing.
The samples were directly inoculated onto chromID CARBA prototype medium (bioMerieux,Marcy l'Etoile, France), which contains a proprietary mixture of antibiotics that favour the selective growth of carbapenemase-producing Enterobacteriaceae (CPE) [17] . On these chromogenic agar plates, presumptive CPE colonies were considered to be those coloured according to the manufacturer's instructions (green-blue to brown-green, pink to burgundy or brown colonies). For all presumptive CPE isolates, carbapenemases were detected via combined-disk tests using meropenem with and without phenylboronic acid (PBA), EDTA or both, as recommended by EUCAST [18] . The chromID CARBA agar plates were also inoculated with the following control strains: carbapenemase-negative K. pneumoniae ATCC 700603 and carbapenemase-positive K. pneumoniae ATCC BAA-1705.
Clinical samples
Blood cultures were obtained from all patients with clinical signs of BSI, according to the guidelines from the Centers for Disease Control and Prevention [19] .
Blood specimens were inoculated into BACTEC Plus Aerobic/F, Plus Anaerobic/F and Mycosis IC/F (MICF) culture vials (BD Diagnostic Systems, Sparks, MD, USA). After inoculation, the culture vials were loaded into BACTEC 9120 blood culture instruments per the manufacturer's instructions (BD Diagnostic Systems, Sparks, MD, USA). Only the first positive blood culture sample per patient was included in the analysis to prevent data duplication.
Antimicrobial susceptibility testing
CRKP isolates from both blood and initial rectal screening samples were identified to the species level and subjected to susceptibility testing using the VITEK 2 automated system (bioMerieux, Marcy l'Etoile, France). The MICs of imipenem, meropenem, ertapenem and tigecycline were determined using E-tests (bioMerieux, Marcy l'Etoile, France) following the Clinical and Laboratory Standards Institute (CLSI) guidelines and interpretative criteria. The MICs of colistin were determined and interpreted according to EUCAST guidelines (EUCAST clinical breakpoints Table v 
Targeted molecular analysis and clonal relatedness
CRKP strains (n=96) isolated from both blood cultures (n=48) and corresponding patient rectal specimens (n=48) were screened by PCR for the bla KPC , bla VIM-like , bla NDM-like and bla OXA-48-like genes [20] . All isolates were typed by multilocus sequence typing (MLST) according to the protocols described for K. pneumoniae MLST [21] .
The genetic relatedness among CRKP strains from rectal and blood samples of 12 representative patients (three hospitalized in 2011, three in 2012, three in 2013 and three in 2014) was evaluated by PFGE analysis of chromosomal restriction fragments obtained following cleavage with XbaI (New England BioLabs, GmbH Frankfurt am Main, Germany). A dendrogram was generated by UPGMA illustrating the relatedness of the PFGE profiles between these representative patients. One ICU environmental epidemic strain, belonged to St259 was also included for comparison. The isolates were considered to belong to the same PFGE group if their Dice similarity index was ≥80% [22] .
Statistical analysis
Statistical analysis was performed using the IBM Statistical Package for Social Sciences for Windows, Version 22. Univariate analysis was performed separately for each variable. To test normality, we first applied the Kolmogorov-Smirnov (KS) test for continuous variables. If normality was rejected, association with the dependent variables was tested using the Mann-Whitney (MW) U-test. Otherwise, Student's ttest was applied for the normal samples. For all statistical analyses, P<0.05 was used to indicate statistical significance. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to evaluate the strength of any association. Categorical variables were compared using the chi-square test. For 2×2 tables, Yate's correction of the chi-square test was performed. Binary logistic regression with forward stepwise (Wald criterion) variable selection was used to identify the most significant variables for each dependent variable. All variables that were used individually earlier were entered in the model. Receiver operating characteristic curves were constructed for logistic regression models. The area under the curve values were determined to estimate the predictive power of each specific logistic regression model.
RESuLTS
Patients' characteristics
Among the 1116 patients admitted to the ICU during the study period, 498 (277 males and 221 females) patients with a median age of 72 years (range of 18-95 years) were enrolled in the study. A total of 120 patients were transferred to our ICU from another hospital, 245 had been previously hospitalized in surgical wards and 117 in medical wards, and the remaining 16 patients had no history of previous hospitalization and were admitted to the ICU directly from the emergency department.
The median length of ICU stay was 8 days (range of 3-61 years), and the median APACHE II score was 18.
Time-to-event analysis
Throughout the study period, a total of 226 patients (45.4%) became rectally colonized by CRKP after a median time of 8 days (range: 2-37 days). The average number of patients colonized monthly was 6 (range: 3-12 patients). Among the CRKP-colonized patients, 48 (21.2%) developed CRKP BSI. Thus, a BSI versus asymptomatic carriage ratio of 1:5 was observed (Fig. 1) . The median time from CRKP colonization to BSI was 4 days (range, 0-42 days, Fig. 2 ).
Risk factors for CRKP colonization
In the univariate analysis, significant factors related to CRKP colonization included prolonged ICU stay, diabetes mellitus, immunodeficiency, patient/nurse ratio and prior antimicrobial use (Table 1) . Among them, the length of ICU stay, patient/nurse ratio and antimicrobials that disturb the anaerobic flora were independent risk factors for CRKP colonization in the multivariate analysis (Table 1) .
Risk factors for CRKP infection among colonized patients: a clinical case-cohort study
The length of ICU stay, patient/nurse ratio and antimicrobials administered in the ICU (primarily colistin, clindamycin, carbapenems and tigecycline) were associated with CRKP BSI among the colonized patients in the univariate analysis (Table 2) .
Conversely, no specific predictor for CRKP BSI was identified among the colonized patients in the multivariate analysis.
Antimicrobial susceptibility testing and molecular typing
All strains (n=96), which included two isolates per patient -one each from blood and rectal samples -were positive for the presence of the bla KPC-2 gene. None of the isolates were positive for the bla VIM-like , bla NDM-like and bla OXA-48 genes.
MLST revealed that all isolates belonged to the sequence type (ST)−258. The PFGE results showed that the BSI and rectal strains from the same patients were identical (Fig.  3) . Strains from different patients isolated during the study period were clonally related and shared similarity greater than 80% (Fig. 3) . Antimicrobial susceptibility testing showed that all 96 isolates exhibited high-level resistance to carbapenems (MICs≥32 µg ml −1 ). Overall, 92 strains were susceptible to colistin (MICs≤0.5 µg ml −1 ), while 4 were colistin resistant (MICs≥32 µg ml −1 ). In total, 86 isolates were susceptible to tigecycline (MICs≤2 µg ml −1 ). Half of the isolates were resistant to amikacin (MICs≥16 µg ml −1 ), and 26 were resistant to gentamicin (MICs≥4 µg ml −1 ).
dISCuSSIon
CRKP strains constitute a substantial public health problem. Public health authorities have sounded the alarm in Europe, the United Kingdom and the United States to rein in the unnecessary use of antibiotics, stimulate the development of new classes of antibiotics and prioritize infection control [23] . In Greece, CRKP has emerged as a notable cause of Colonization by potential pathogens is almost always a prerequisite for the development of nosocomial infections [26] . Active surveillance is strongly recommended for the timely detection of CRKP carriers, patient isolation or patient cohorting and the activation of contact precautions [27] .
In the present study, we observed that almost half (45.4%) of ICU patients became rectally colonized by CRKP post-ICU admission within a median of 8 days. The multivariate analysis revealed that CRKP colonization was associated with antianaerobic antibiotic exposure during the prior 6 months, patient/nurse ratio and duration of ICU hospitalization. Different risk factors were found by Papadimitriou-Olivgeris et al. [28] and Nouvenne et al. [29] , who also studied colonization in ICU patients.
Anaerobic bacteria predominate the human intestinal microbiota and play an important role in maintaining a healthy gut [30] . In the present study, we showed that antibiotic regimens with potent antianaerobic activity (e.g. metronidazole and clindamycin) promoted CRKP colonization. In contrast, antibiotic regimens with minimal antianaerobic activity (e.g. ciprofloxacin and aminoglycosides) did not. The normal anaerobic intestinal flora is an important host defense mechanism that inhibits the colonization of potentially pathogenic micro-organisms, and treatment with antianaerobic antibiotics disturbs the stability of the gut microbiota [31, 32] . Furthermore, the gut epithelium can be profoundly altered in critically ill ICU patients, allowing colonization with multidrug-resistant micro-organisms to occur rapidly [33] . Thus, the gut of ICU patients constitutes a major reservoir of Klebsiella pneumoniae [34] .
In our study, patients who received an antibiotic with activity against anaerobes showed an increased rate of CRKP gut colonization (P<0.001, OR=85.55). Perez et al. [35] assessed the effects of antibiotic treatment on the concentrations of total anaerobes and Bacteroides spp. in stool samples of experimentally infected mice. They observed that antibiotics that disturb the intestinal anaerobic microflora and lack significant activity against CRKP promote colonization by this organism, unlike agents that do not suppress total anaerobes or Bacteroides (i.e. ciprofloxacin) [35] . In this study, the prior use of carbapenems, beta-lactamase inhibitors, linezolid, vancomycin, metronidazole and clindamycin were the most specific risk factors for CRKP colonization. Our findings confirmed those of several previous studies, which reported prior exposure to carbapenems as an independent risk factor for CRKP colonization [36, 37] . In contrast, in the present study as well as in the studies conducted by Jiao et al. [38] and Kwak et al. [39] , prior treatment with quinolones and aminoglycosides were not associated with CRKP colonization. However, data regarding the use of fluoroquinolones as a risk factor for KPC colonization remain controversial [38] [39] [40] [41] . Several studies have shown that the use of quinolones is an independent risk factor for KPC colonization/infection [40, 41] . Nevertheless, Rafii et al. [42] investigated the effects of treatment with antimicrobial agents on the human colonic microflora and demonstrated that none of the fluoroquinolones affected the anaerobic bacterial population. In another study, Hecker et al. [43] examined how often antimicrobials, particularly those with antianaerobic activity, were used unnecessarily in ICU patients. They observed that antianaerobic agents accounted for 203 (35%) of 576 unnecessary antimicrobial days of therapy and that these agents were also frequently prescribed (98 days of therapy) when equally efficacious alternative regimens with minimal antianaerobic activity were available [43] .
The patient/nurse ratio (P<0.001) was another important factor in our findings. Several studies have observed a significant relationship between lower nursing staff numbers and higher rates of nosocomial infections [44, 45] . The primary conclusion from our analysis was that staffing levels were suboptimal in relation to the increased frequency of CRKP colonization, making it difficult to apply nurse cohorting for CRKP patient care. Specifically, the patient/nurse ratio was high for 77% of the colonized patients who developed subsequent BSI. This result could potentially be attributed to decreased compliance with personal protective equipment when nurse/patient ratios are higher. Consequently, having an adequate nursing staff is important for the prevention of CRKP transmission.
Another independent risk factor for CRKP colonization was the duration of stay in the ICU (P<0.001). In CRKP-colonized patients, the average length of stay was longer (19 days) than that of the non-colonized patients (8 days). The results of our study suggest that a longer stay in the ICU is associated with a high rate of CRKP colonization, which is consistent with the studies conducted by Schwaber et al. [41] and Gregory et al. [46] .
The second goal of our study was to determine which asymptomatic carriers are prone to develop a BSI. Within a median of 4 days following the detection of CRKP colonization, 21.2% of the colonized patients developed a BSI. Prospective studies that have evaluated the frequency and risk factors associated with CRKP BSIs in patients rectally colonized with CRKP are limited [41, 47, 48] . In a similar study in Israel, Borer et al. [47] observed that 9% of CRKP carriers developed a clinical infection, and Schechner et al. [40] exclusion of high-risk patients. In contrast, the high infection rates observed in our study may be associated with patient complexity that required more invasive procedures and longer ICU stays under high colonization pressure compared to that of the previous studies. Currently, little is known regarding the predictors of BSI among CRKP carriers. The extent to which colonized patients develop BSIs remains unclear. Schechner et al. [40] observed that the use of fluoroquinolones and metronidazole were independent risk factors for CRKP infection in asymptomatic carriers. In contrast, Amit et al. [48] , similar to the present study, did not observe any specific factor for subsequent BSI among rectal carriers. Our results indicate that both microbial characteristics (such as pathogenic virulence mechanisms) and host defense mechanisms may play important roles in the development of BSIs in colonized patients.
Finally, our molecular results support the strong association between colonization and BSI and indicate that hospitalized patients become infected with their colonizing strains. Additionally, they confirmed that a long-term outbreak of an ST-258 K. pneumoniae clonal strain producing KPC-2 occurred. The outbreak was effectively controlled at the beginning of 2015 after the implementation of strict measures and increased nursing staff. Since then, the rate of colonization has decreased significantly, and only sporadic cases have been detected.
There are some important limitations of our study that should be acknowledged. First, the study was performed at a single center, and the results may not be generalizable to other institutions. Second, the risk factors identified in the present study are relevant to regions with endemic/ongoing outbreaks of CRKP strains and may not be generalizable to other settings with a lower prevalence of KPC or strains with different resistance mechanisms.
Our findings suggest that CRKP colonization is associated with several risk factors. Furthermore, a direct correlation between colonization and the progression to BSI was demonstrated. The early detection of asymptomatic CRKP carriers in conjunction with rigorous control measures (contact precautions, handhygiene, and patient cohorting) and the appropriate management of antibiotic therapy are crucial to prevent the spread of CRKP stains in ICUs.
